BioSpace News Archive

Tryp Therapeutics Inc. is pleased to announce the appointment of Australia-based Jason Carroll as the Company’s new Chief Executive Officer, beginning October 1, 2023.

Global health company The Cigna Group reported strong second quarter 2023 results reflecting growth and focused execution across our diversified portfolio of businesses.

Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the second quarter ended July 2, 2023.

Henry Schein, Inc., the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced that it has signed an agreement to acquire a majority ownership position in Shield Healthcare, Inc., a leading supplier of homecare medical products delivered directly to patients in their homes.

Karuna Therapeutics, Inc. announced financial results for the second quarter of 2023 and provided a general business update.

Karuna Therapeutics, Inc. announced the appointment of Jonathan Rosin to Chief Human Resources Officer and the promotion of Jason Brown to Chief Financial Officer.

Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease Merck, known as MSD outside of the United States and Canada, announced that the U.S. Food and Drug Administration has approved an expanded indication for ERVEBO, which is now indicated for the prevention of disease caused by Zaire ebolavirus in individuals 12 months of age and older.

Renalytix plc announces the launch of its Clinical Advisory Board, a world-leading, multi-disciplinary clinical group, to help advance the use of FDA authorized kidneyintelX.dkd™ in mitigating uncontrolled kidney disease progression and guiding early stage treatment strategies for the estimated 14 million Americans with diabetic kidney disease.

Orchard Therapeutics, a global gene therapy leader, announced several business accomplishments along with its financial results for the quarter ended June 30, 2023.

Plus Therapeutics, Inc. announced that Marc Hedrick, M.D., President and Chief Executive Officer, has been invited to present at the Canaccord Genuity 43rd Annual Growth Conference, on Wednesday, August 9, 2023 at 8:00 a.m. ET at the InterContinental Boston in Boston, Mass.